Finding biomarkers for aggressive prostate cancer
A new study published in European Urology identifies biological markers in blood proteins that may help predict the risk of aggressive prostate cancer. These findings offer potential for improved early detection and personalized risk assessment for men.
Why it matters
Prostate cancer is a leading cause of cancer-related death in men, and better diagnostic tools are essential for improving patient outcomes.
(c) Sharne T/peopleimages.com - stock.adobe.com
The findings reveal biological differences between men who later developed prostate cancer and those who did not, and may help guide future studies aimed at identifying men at greater risk of the disease. The study, published in European Urology and presented at the American Society of Human Genetics (ASHG) Annual Meeting, is the largest population-based investigation to date of blood proteins and future prostate cancer risk, with a particular focus on aggressive disease.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in